Staphyloma and Atrophy with Vitreoretinal tractionvu 21 foisOnly eye of patient with Albinism and decreasing vision now 5/200 in this 72 year old man. There is myopic tractional maculopathy. The patient also has albinism by history.13 Avril 2026
Staphyloma and Atrophy with Vitreoretinal tractionvu 25 foisOnly eye of patient with Albinism and decreasing vision now 5/200 in this 72 year old man. There is myopic tractional maculopathy. The patient also has albinism by history.13 Avril 2026
Staphyloma and Atrophy with Vitreoretinal tractionvu 26 foisOnly eye of patient with Albinism and decreasing vision now 5/200 in this 72 year old man. There is myopic tractional maculopathy. The patient also has albinism by history.13 Avril 2026
Conversion to Wet AMD after Izervayvu 33 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 39 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 31 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 40 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 33 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 25 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 36 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 33 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 36 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 30 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 30 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 26 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 36 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 30 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 28 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 30 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 29 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Pattern Dystrophy with Collapsed Vitelliformvu 126 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 116 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 121 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 61 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 55 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 57 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 48 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 55 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 50 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 56 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 52 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 62 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 59 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 39 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 42 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 40 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 40 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 41 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 47 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 48 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 33 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 52 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 40 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 32 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 30 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 40 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Peripapillary CNVM No Treatmentvu 57 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 29 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 41 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 39 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 27 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 29 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 40 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 39 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 33 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 32 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 27 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 21 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 30 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 26 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 27 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 36 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 29 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 28 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 37 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 43 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 32 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 35 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 35 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 39 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 39 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 22 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 37 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 36 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 31 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 42 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 50 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 36 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 54 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 43 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 46 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 45 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 47 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 41 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 37 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 52 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 42 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 50 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 45 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 42 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 47 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 43 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 56 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Stable Myopic Tractional Maculopathyvu 48 fois73 year old female with mild vision loss from table myopic tractional maculopathy in the left eye23 Novembre 2025
Stable Myopic Tractional Maculopathyvu 41 fois73 year old female with mild vision loss from table myopic tractional maculopathy in the left eye23 Novembre 2025
Stable Myopic Tractional Maculopathyvu 46 fois73 year old female with mild vision loss from table myopic tractional maculopathy in the left eye23 Novembre 2025
Stable Myopic Tractional Maculopathyvu 41 fois73 year old female with mild vision loss from table myopic tractional maculopathy in the left eye23 Novembre 2025
Stable Myopic Tractional Maculopathyvu 40 fois73 year old female with mild vision loss from table myopic tractional maculopathy in the left eye23 Novembre 2025
Stable Myopic Tractional Maculopathyvu 46 fois73 year old female with mild vision loss from table myopic tractional maculopathy in the left eye23 Novembre 2025
Stable Myopic Tractional Maculopathyvu 35 fois73 year old female with mild vision loss from table myopic tractional maculopathy in the left eye23 Novembre 2025
